Company intelligence / Profile preview

Redwood Bioscience

Emeryville, California, United States

Ownership: Private
Development stage: Other

Overview

Redwood's SMARTag technology delivers precise, site-specific conjugation for antibody-drug conjugates and biotherapeutics, enabling improved potency, stability, and safety; demonstrated improved therapeutic index versus conventional ADC approaches

Modalities: Antibody-drug conjugateProteinBiologic
Industry: Drug Discovery Services

Partnerships

Catalent (exclusive licensing leading to acquisition)partnered with pharma/biotech that license SMARTag (undisclosed, potentially confidential)

Beyond the preview

Go deeper on Redwood Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redwood Bioscience.

Explore the full profile